EP1969134A4 - Modified release amoxicillin products - Google Patents

Modified release amoxicillin products

Info

Publication number
EP1969134A4
EP1969134A4 EP06847542A EP06847542A EP1969134A4 EP 1969134 A4 EP1969134 A4 EP 1969134A4 EP 06847542 A EP06847542 A EP 06847542A EP 06847542 A EP06847542 A EP 06847542A EP 1969134 A4 EP1969134 A4 EP 1969134A4
Authority
EP
European Patent Office
Prior art keywords
modified release
release amoxicillin
amoxicillin products
products
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06847542A
Other languages
German (de)
French (fr)
Other versions
EP1969134A1 (en
Inventor
Donald Treacy
Alan R Potts
Henry H Flanner
Beth A Burnside
Sanna Tolle-Sander
Susan P Clausen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi Inc
Original Assignee
Advancis Pharmaceutical Corp
MiddleBrook Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/633,315 external-priority patent/US8778924B2/en
Priority claimed from US11/634,633 external-priority patent/US20080139526A1/en
Application filed by Advancis Pharmaceutical Corp, MiddleBrook Pharmaceuticals Inc filed Critical Advancis Pharmaceutical Corp
Publication of EP1969134A1 publication Critical patent/EP1969134A1/en
Publication of EP1969134A4 publication Critical patent/EP1969134A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
EP06847542A 2005-12-08 2006-12-08 Modified release amoxicillin products Withdrawn EP1969134A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US74866005P 2005-12-08 2005-12-08
US79810906P 2006-05-05 2006-05-05
US11/633,315 US8778924B2 (en) 2006-12-04 2006-12-04 Modified release amoxicillin products
US11/634,633 US20080139526A1 (en) 2006-12-06 2006-12-06 Modified release dosage forms of amoxicillin
PCT/US2006/047107 WO2008069806A1 (en) 2005-12-08 2006-12-08 Modified release amoxicillin products

Publications (2)

Publication Number Publication Date
EP1969134A1 EP1969134A1 (en) 2008-09-17
EP1969134A4 true EP1969134A4 (en) 2011-12-21

Family

ID=39492508

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06847542A Withdrawn EP1969134A4 (en) 2005-12-08 2006-12-08 Modified release amoxicillin products

Country Status (3)

Country Link
EP (1) EP1969134A4 (en)
AU (1) AU2006351475B2 (en)
WO (1) WO2008069806A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010048944A1 (en) * 2000-02-24 2001-12-06 Rudnic Edward M. Antibiotic product, use and formulation thereof
US20020136766A1 (en) * 2000-02-24 2002-09-26 Rudnic Edward M. Tetracycline antibiotic product, use and formulation thereof
US20030077323A1 (en) * 2000-02-24 2003-04-24 Rudnic Edward M. Amoxicillin - clarithromycin antibiotic composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5911969A (en) * 1992-06-09 1999-06-15 Neorx Corporation Pretargeting protocols for enhanced localization of active agents to target sites
US6878386B1 (en) * 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US20040208936A1 (en) * 2002-07-22 2004-10-21 Roland Chorin Novel compositions
AU2004308419B2 (en) * 2003-12-24 2011-06-02 Victory Pharma, Inc. Enhanced absorption of modified release dosage forms

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010048944A1 (en) * 2000-02-24 2001-12-06 Rudnic Edward M. Antibiotic product, use and formulation thereof
US20020136766A1 (en) * 2000-02-24 2002-09-26 Rudnic Edward M. Tetracycline antibiotic product, use and formulation thereof
US20030077323A1 (en) * 2000-02-24 2003-04-24 Rudnic Edward M. Amoxicillin - clarithromycin antibiotic composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2008069806A1 *

Also Published As

Publication number Publication date
AU2006351475A1 (en) 2008-06-12
EP1969134A1 (en) 2008-09-17
WO2008069806A8 (en) 2008-10-02
AU2006351475B2 (en) 2013-08-15
WO2008069806A1 (en) 2008-06-12

Similar Documents

Publication Publication Date Title
ZA200902775B (en) Novel products
IL185105A0 (en) Fast-release microcapsule products
IL192905A0 (en) Novel products
ZA200806847B (en) Novel products
IL191534A0 (en) Pathogen-controlling products
GB0621484D0 (en) Novel products
IL192903A0 (en) Novel products
ZA200708807B (en) Instant product
GB0624308D0 (en) Combination product
EP1968410A4 (en) Clasp
GB0618706D0 (en) Products
GB0817640D0 (en) Pan release products
GB2428958B (en) Snackfood product
PT1876916E (en) Product
GB0625691D0 (en) Combination product
GB0524520D0 (en) Product
GB0504589D0 (en) Product
EP2087981A4 (en) Master and microreactor
GB0515480D0 (en) Product
ZA200805267B (en) Pathogen-controlling products
GB0720757D0 (en) Novel products
GB0610132D0 (en) Novel products
EP1969134A4 (en) Modified release amoxicillin products
GB0507976D0 (en) Products
GB0617552D0 (en) Pathogen-controlling products

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080708

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1120081

Country of ref document: HK

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MIDDLEBROOK PHARMACEUTICALS, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20111117

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/50 20060101ALI20111111BHEP

Ipc: A61K 9/54 20060101ALI20111111BHEP

Ipc: A61K 9/52 20060101ALI20111111BHEP

Ipc: A61K 9/24 20060101ALI20111111BHEP

Ipc: A61K 9/20 20060101ALI20111111BHEP

Ipc: A61K 9/14 20060101AFI20111111BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SHIONOGI INC.

17Q First examination report despatched

Effective date: 20120713

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200701

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1120081

Country of ref document: HK